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ABSTRACT 
DEVELOPMENT OF AN ELECTROSPUN AND 3D PRINTED CELLULAR DELIVERY 
DEVICE FOR DERMAL WOUND HEALING 
 
By 
Ryan M. Clohessy, B.S. 
 
A dissertation submitted in partial fulfillment of the requirements for the degree  
Doctor of Philosophy at  
Virginia Commonwealth University 2017. 
 
Advisor: Zvi Schwartz, D.M.D., Ph.D., Associate Dean for Strategic Initiatives, 
Professor, Department of Biomedical Engineering, Virginia Commonwealth University 
 
 The goal of this research was to develop a system of individualized medicine that 
could be applied to dermal wounds serving as a wound dressing and synthetic 
extracellular matrix while delivering stem cells to the wound bed.  First, fabrication 
parameters for electrospinning polymer fibers were determined.  This involved evaluating 
fiber morphology with respect to polymer selection and solution concentration.  Next, 
construct fabrication was examined to produce an integrated void space, or cargo area, 
suitable to maintain stem cells.  In vitro studies to ensure stem cell viability and phenotype 
were conducted, and results supported the notion that cells could be administered to the 
wound site through construct pre-seeding.  Lastly, in vivo studies were conducted to 
evaluate the construct as an applied biomaterial and as a cellular delivery device.  Wound 
closure and quality were assessed, and neo-vascularization quantified.  This project will 
provide insight into the tissue engineering field regarding cell-based therapies and dermal 
wound healing. 
2 
 
CHAPTER 1 
Background and Literature Review 
Wound Healing and Regeneration 
 Wounds are described as a defect or break in the skin resulting from physical or 
thermal damage or as a result of the presence of an underlying medical or physiological 
condition [4].  Normal wound healing is a process with four overlapping phases: 
Hemostasis and Inflammation, Migratory, Proliferative, and Remodeling.  Bleeding 
usually occurs when the skin becomes damaged and flushes bacteria and antigens from 
the wound site.  The clotting cascade, a sequence of clotting factor activation forms a 
fibrin plug to stop the bleeding.  This clot provides hemostasis and occurs as the 
inflammation stage begins.  Vasodilation occurs as a response to histamine and serotonin 
[4] which allows phagocytes to enter the wound and begin digesting necrotic tissue.  The 
migratory phase occurs when fibroblasts and epithelial cells are recruited to the wound 
and begin to replace lost or damaged tissue.  The proliferation phase begins with or 
immediately after the migratory phase.  In this phase, granulation tissue is formed while 
blood and lymphatic vessels grow into the wound.  Collagen matrix production is 
increased and lends to the strength and shape of the new skin.  Finally, the remodeling, 
or maturation phase, occurring several weeks up to two years, strengthens the new 
epithelium and forms additional cellular connective tissue and matrices[5].   
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Figure 1: Phases of the wound healing cycle: 1. Inflammatory Phase 2. Migratory 
Phase 3a. Proliferative Phase 3b. Remodeling Phase [4]. 
 Regeneration is typically a process that occurs when the wound is superficial and 
the original tissue can be exactly restored.  When the wound is deeper, impacting the 
dermis, regeneration is not possible and wounds are closed through repair, usually 
resulting in scar tissue [6].  Generally, wounds which are able to re-epithelialize within 2 
weeks do not form scars as minimal collagen is deposited.  However, wounds which do 
not become covered with epithelial tissue within this time form scars as excess collagen 
builds up.  The excess collagen fibers have a pronounced alignment which results in 
inferior functional quality to the random alignment of normal tissue.   
Wounds that do not heal within expected timeframes are considered chronic 
wounds.  These wounds have had the healing process interrupted at one or more stages 
and are the focus of the work herein.  Chronic wounds may be a result of a patients’ 
underlying condition or an outside influence such as a pathogenic bacterial infection.  In 
either case, chronic wounds need additional influences and support to be jump started 
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back into the wound healing process.  Clinically, this will often be accomplished with a 
graft to support the wound bed and help reestablish the lost tissue. 
The focus of this research proposal will be on engineering a construct that supports 
host cell ingrowth, and is able to deliver a cellular payload, specifically stem cells, and 
their secreted soluble factors such as VEGF, BMP2, and FGF.  Designed to supplement 
or replace tissue grafting and support wound healing, the construct developed herein will 
support both ‘fresh’ and chronic wounds and promote regeneration. 
Tissue Engineering of Skin 
 Tissue engineering is the development of native tissue substitutes that are able to 
repair and regenerate damaged tissue to return natural function and state [7].  Skin, the 
largest organ of the human body, functions to protect against environmental hazards.  
Safeguarding the internal milieu from instability, life cannot be sustained without it.  Tissue 
engineering of skin is a complicated process as skin is composed of three layers, the 
epidermis, basement membrane, and the dermis, which together provide for the skin’s 
functions.  The epidermis is composed primarily of keratinocytes and is separated from 
the dermis by the basement membrane but functionally connects both layers. The dermis 
contains the extracellular matrix composed of collagen, reticulum fibers, elastin and 
glycosaminoglycans, and is primarily populated by fibroblasts [8].    
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Figure 2: The Structure of Human Skin [2]. 
 
Historically, complex wounds requiring more than bandages or dressings have 
been treated with autografts, allografts, or xenografts.  Autografts are skin grafts, or layers 
of skin that have been harvested from elsewhere on the patient’s body and are 
transplanted onto the wound site.  Currently, this technique is the ‘gold standard’ as there 
is no risk of disease transmission and the possibility of rejection is minimized as the tissue 
is the patient’s own.  Allografts are skin grafts taken from a donor.  Usually cadaveric in 
origin, these grafts have the potential to transmit disease from donor to patient, as well 
as be rejected by the patient through an immune response.  The last type of graft is a 
xenograft.  Xenografts are animal derived grafts, generally porcine, and are usually 
irradiated or treated to help prevent xenogeneic cells from transmitting diseases or 
eliciting an immune response. Xenografts are generally used as a temporary graft or 
covering until an autograft or appropriate alternative can be implemented. 
 Recently, research has been focused on synthetic skin grafts and skin substitutes.  
These may be cellular or acellular and often incorporate antimicrobials, growth factors, or 
supplements [4].  Acellular grafts are made from synthetic collagen and hyaluronic acid 
or are cultured sheets that have been decellularized, preserving the dermal shape and 
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matrix properties.  Cellular grafts are generally biodegradable films which have been 
loaded with autologous or recombinant skin cells [9].  Recently cultured epidermal 
autografts have been extensively studied, with six cellular synthetic grafts commercially 
available. An ideal skin substitute would improve on each of these current techniques and 
possess the following characteristics: inexpensive, analgesic, long shelf life, be used off 
the shelf, non-antigenic, durable, flexible, prevent water loss, antimicrobial, conform to 
irregular wounds, easy to secure, grow with children, and able to be applied in a single 
operation. 
 
Polyglycolic Acid (PGA) 
Polymer selection plays a critical role in designing a scaffold for tissue engineering.  
The polymer must meet certain criteria such that the scaffold is nontoxic, biocompatible, 
biodegradable, and does not illicit a severe immune response.  The polymer of choice 
should also have a predictable degradation pattern as well as a quantifiable drug/protein 
release profile.  Polyglycolic acid is a biodegradable polymer and the simplest linear, 
aliphatic polyester.  It is known to be biocompatible, nontoxic, and degrades to glycolic 
acid monomers [25, 26].  The buildup of protons will reduce the pH of the wound 
microenvironment and may be a pro-angiogenic influence [10]. The byproducts of 
degradation can be processed by the body through the tricarboxylic acid cycle and 
excreted as water and carbon dioxide, with remaining parts excreted through urine.  
Commonly used in resorbable sutures, PGA has a proven track record in the biomedical 
community [26].  PGA used in this study was PGA 100 from Lakeshore Biomedical/Evonik 
(Birmingham, AL, USA).   
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Figure 3: Chemical structure of polyglycolic acid. 
Poly-Ethylene Glycol (PEG) 
 Poly-ethylene glycol is a water-soluble polymer which, when added to the polymer 
solution, acts as a stabilizer and can ease the electrospinning processing [28].  This 
occurs by modifying the viscosity of the polymer solution.  The addition of PEG also aids 
in manipulating the degradation rate of the scaffold as it increases the water uptake of the 
polymer blend thus increasing the rate of degradation [11]. Lastly, PEG can also improve 
the hydrophilicity of PGA scaffolds [28]. PEG used in this study was from Fluka, 
Polyethylene Glycol 20,000 (MW).   
 
Figure 4: Chemical structure of polyethylene glycol. 
Polyvinyl Alcohol (PVA) 
 Polyvinyl alcohol is generally regarded as safe, biocompatible and is used in many 
biomaterials [12, 27].  It is water soluble and available in 3D printer filament making it an 
ideal material choice to form the void fillers (as 3D printed PVA dissolves in static water 
within four hours).  PVA used here is undyed, natural color from UltiMachine in 1.75mm 
diameter filament on a 1kg spool (South Pittsburg, TN, USA). 
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Figure 5: Chemical structure of polyvinyl alcohol.  
3D Printing 
 3D printing of the void space templates was done using a MakerBot X2 printer 
(New York, New York, USA).  The printer head is able to control extrusion temperature, 
bed temperature, print speed, and layer height. For template printing, we used an 
extrusion temperature of 190°C onto an unheated print bed, with a print speed of 
90mm/sec and layer height of 0.1mm.  Void templates were constructed in three pieces 
to allow for layer-by-layer fabrication and electrospun fiber deposition between each level. 
Electrospinning 
 Electrospun polymeric scaffolds are non-woven fibrous meshes with fiber 
diameters on the order of microns. Scaffolds can be designed to various thicknesses and 
cut to match size and shape needs. Tailoring of the polymer solution can regulate the 
degradation rate. These characteristics are greatly affected by the high surface area to 
volume ratio fibrous scaffolds possess over solids.  Electrospinning is preferable to woven 
materials because the seemingly random orientation of the fibers more closely matches 
that of the ECM.  Scaffolds were electrospun through a Becton Dickenson 18G 1” blunt 
tip needle, fed via a KD Scientific Variable Syringe Pump.  The polymer solution will be 
charged using a Spellman CZE 1000 R high voltage power supply and collected on a 
grounded target.  Solution feed rates, voltages, and distance were tailored to produce a 
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scaffold with optimal characteristics. Scaffolds for this study are formed by dissolving the 
polymer blend in hexafluoroisopropanol (HFP) by TCI America (1,1,1,3,3,3 Hexafluoro-2 
propanol). 
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Abstract 
Cell-based therapies have garnered significant attention in recent years. As a treatment, 
the therapeutic effectiveness of the cells is often directly correlated to their ability to 
remain at the target locale. In an effort to provide localized delivery, we have developed 
a resorbable “bandage” shaped construct with the ability to deliver a payload of cells to 
the treatment site. To do this, a blend of polyglycolic acid (PGA) and polyethylene glycol 
(PEG) was electrospun as part of a custom fabrication method that incorporated 3D 
printed polyvinyl alcohol (PVA) sacrificial elements. Electrospun fibers were 0.55µm 
(±0.2µm), creating a non-woven mesh with pore size of 3.8µm2 (± 2.7µm2). This 
preparation is unique compared to traditional electrospinning as the sacrificial elements 
produce an internal void space for an injectable payload, which may be delivered to the 
target site. Human mesenchymal stem cells (hMSCs) incorporated into the scaffold 
maintained their ability to differentiate while remaining viable over 10 days in culture. 
Taking advantage of this ability may prove beneficial in regeneration, particularly in 
challenged or compromised wounds. 
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1. Introduction 
Tissue engineering approaches for regenerative medicine, such as acellular grafts 
made of collagen or hyaluronic acid, or decellularized tissue matrices, have gained 
popularity in recent years.1-3 Synthetic cellular grafts made of biodegradable films cultured 
with autologous, allogeneic or genetically-modified cells have also begun to be made 
commercially available.4 Although the use of engineered grafts is a step forward in 
regenerative medicine applications, these grafts experience some of the drawbacks of 
conventional grafts, such as a high risk of rejection, transmission of infection, excess 
scarring, and expense to the patient and care providers.5 Delivery of autologous cells has 
mitigated some of the drawbacks but their effectiveness often depends on the delivery 
method used. Synthetic scaffolds can reduce the risk of rejection, especially when used 
with autologous cells, putting these technologies at the forefront of medical engineering. 
Therefore, there is a great need for a biodegradable, synthetic, off-the-shelf materials that 
can deliver a cellular payload.  
 Electrospinning is a versatile process that can produce micro- to nano-sized fibers 
from a polymer solution that can closely mimic the extracellular matrix.6, 7 We applied this 
technique to produce a randomly oriented microfiber scaffold from two polymers, 
poly(glycolic acid) (PGA) and poly(ethylene glycol) (PEG), and used polyvinyl alcohol 
(PVA) to create a void space pocket for a payload of cells or therapeutic agents. These 
components were selected because of their individual attributes. PGA is a biodegradable 
polymer that is found most commonly in resorbable surgical sutures. PGA scaffolds can 
support a variety of cells8-10. However, during degradation, they can also result in an acidic 
microenvironment at the wound site11, which may encourage angiogenesis.12 PEG is a 
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water-soluble polymer that facilitates more uniform electrospun fibers, as well as allowing 
modification of fiber degradation.13 PVA is 3D printed into sacrificial elements that are 
removed prior to clinical use. By incorporating it into the device as a spacer, we were able 
to generate a three dimensional (3D) “bandage” construct.  
The randomly oriented fibers of the scaffold allow native cells from the treatment 
site to attach and proliferate into the 3D environment created by the fiber mesh, 
contributing to the healing and remodeling processes.14 By incorporating an internal void 
space, a payload can be delivered to the target location. Using 3D printing together with 
an appropriate void space filler, nearly limitless configurations of the cargo area can be 
designed and included within the construct. Here we chose a 1cm x 1cm square template 
as this resulted in a construct that nicely fit a 12-well plate for in vitro testing. The payload 
can consist of cells, bioactive factors, or combinations of agents. We selected human 
mesenchymal stem cells (MSCs) as the payload, based on observations that addition of 
MSCs to wound sites has been noted to improve healing and regeneration outcomes.15-
18 
 The aim of this study was to develop a better bandage; namely, a resorbable 
wound dressing that could deliver and localize a payload of cells while serving as a matrix 
for host cell ingrowth. To achieve our aim, we first developed a design to provide both an 
enclosed volume for a cellular payload and sufficient surface area to allow the cells to 
adhere. We next optimized the polymer solution and electrospinning parameters and 
characterized the construct to determine the fiber diameter and pore size of the microfiber 
component. The completed construct was then assessed for its degradation rate and 
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suitability for cell growth. Finally, the construct was evaluated for any influences it might 
have on cell behavior.  
2. Materials and methods 
2.1 Overview of construct fabrication  
Final constructs were fabricated using a combination of techniques, which are 
described briefly here and shown in Figure 1A. Sub-micron fibers were vertically 
electrospun onto a flat aluminum foil target. Layers of electrospun fibers were alternated 
with 3D printed ‘void templates’ until a seven-layer construct was complete. Before 
positioning the second and third layers of 3D printed sacrificial elements, small cuts were 
made in the covering electrospun fiber layer.  This allowed contact between sacrificial 
elements along two parallel edges, thereby forming an interconnected “reservoir.” The 
completed constructs were air-dried in a vacuum desiccator prior to removing the 
sacrificial elements. After washing out the PVA, the final construct had an interconnected 
void within the electrospun fibers (Figures 1B,C). The appearance of an ‘as-fabricated’ 
construct can be seen in Figure 1C with an exploded view highlighting the internal, 
interconnected PVA sacrificial elements interpolated with electrospun fibers (red arrows). 
Constructs were sterilized by soaking in 70% ethanol for 1 h followed by three five-minute 
rinses in sterile PBS under aseptic conditions.  
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Figure 1: Schematic of fabrication process (A). Photograph of construct as-
fabricated (B) and bisected to reveal internal composition (C).  Arrows in (C) point 
to layers of electrospun fibers between the PVA sacrificial elements. 
2.2 Electrospinning 
 Electrospun scaffolds can be designed to various thicknesses and cut to match 
size and shape needs. Tailoring of the polymer solution can regulate the degradation rate, 
often faster due to the high surface area to volume ratio fibrous scaffolds possess versus 
bulk solids.  In addition, electrospinning is preferable to woven materials because the 
seemingly random orientation of the fibers more closely matches that of the extracellular 
matrix (ECM).19 
To make the constructs in the present study, scaffolds were electrospun through 
a Becton Dickenson 18G 1” blunt tip needle, fed via a KD Scientific Variable Syringe 
Pump.  The polymer solution was charged using a Spellman CZE 1000 R high voltage 
power supply and collected on a grounded target.  Solution composition, feed rates, 
 
 
A. 
B. C. 
Exposed “shoulders” 
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voltages, and distance were tailored to produce a scaffold with optimal characteristics 
defined as smooth and uniform fibers. Multiple polymer blends and parameters were 
tested to down select to the final formulation (Figure 2), which was 140:40 PGA:PEG 
(w:w). Scaffolds for this study were formed by dissolving the polymer blend of polyglycolic 
acid (PGA, i.v. 1.0-2.0, Polysciences Inc., Warrington, PA) and polyethylene glycol (PEG, 
Mw=20,000, Sigma Aldrich, St. Louis, MO) in 1,1,1,3,3,3 hexafluoro-2 propanol (HFP) 
(TCI America, Portland, OR). 
 
Figure 2: Table of polymer solutions tested (left). Scanning electron microscope 
image (right) of fibers produced from down-selected solution 140:40 mg/mL 
PGA:PEG. 1000x 
2.3 3D Printing 
2.3.1 PVA Sacrificial Elements 
 3D printing of the void space templates was done using a MakerBot X2 printer 
(New York, New York, USA).  The printer head is able to control extrusion temperature, 
bed temperature, print speed, and layer height. PVA was selected as the appropriate void 
filler polymer as it is water soluble and available in a 3D printer filament.  For template 
printing, we used an extrusion temperature of 190°C onto an unheated print bed, with a 
print speed of 90mm/sec and layer height of 0.1mm.  Void templates were constructed in 
three pieces to allow layer-by-layer fabrication and designed for interconnection and 
electrospun fiber deposition between each level. These void templates were printed from 
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1.75mm diameter PVA filament (Ultimachine, South Pittsburgh, TN) and evaluated for 
dissolution rate through observation in static conditions over time. Additionally, we 
needed to ensure that the PVA be cleanly removed from a completed construct.  
2.3.2 PVA Dissolution  
Prior to PVA dissolution, the constructs were dried in a vacuum desiccator for a 
minimum of 24 hours, where they remained until used.  In order to determine the optimal 
parameters for PVA dissolution, samples of the void fillers that were printed 5x larger than 
the PVA void fillers used in the bandage were assessed for dissolution over time in static 
de-ionized water under ambient conditions (Figure 3A). The time course of dissolution 
was determined using these PVA constructs; samples were incubated as above for 30, 
60, 90, 120, 150, 180, and 240 minutes (Figure 3B).   
 
Figure 3: PVA dissolution. Test samples were 3D-printed 5x size (A). Change in 
construct morphology in deionized water under static conditions at ambient 
temperatures with water exchanges at every 30 min. 
To ensure PVA washout from the finished constructs (PGA/PEG polymer + PVA 
void filler), each batch of 18 constructs was incubated at room temperature overnight in 
4L of de-ionized water.  To ensure PVA was completely removed from the bandage, SEM 
images were taken before and after the wash-out.  Figure 4 displays the lack of 
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differences between fiber sheets before and after wash-out procedure, indicating that the 
PVA was fully washed out and did not result in any residue build up or particulate remains.  
 
Figure 4: SEM images of fibers before and after PVA wash-out procedure. Center 
photograph indicates the construct layer that the SEM image was taken from. 
2.4 Characterization Methods 
2.4.1 Scanning Electron Microscopy 
Scanning electron microscopy (SEM, Hitachi SU-70, Tokyo, Japan) was used to 
obtain low (35-50x) and high magnification (1000x) images of electrospun fibers. Samples 
were first platinum sputter coated for 85 seconds (Desk V, Denton Vacuum, Moorestown, 
NJ) to ensure electrical conductivity. Images were obtained at an accelerating voltage of 
20 kV, objective aperture of 30 mm, and a working distance of 14 mm. Average fiber 
diameter and pore size were measured using ImageJ software v1.48 (NIH, Bethesda, 
MD, USA). Means ± SD were calculated from three fields of view from each of three 
samples. Fifty measurements were made for each field of view. 
2.4.2 Degradation Characteristics 
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A degradation timeline for the construct as a whole was determined by placing 
washed and desiccated samples of known weight in 50 mL of phosphate buffered saline 
at 37°C on an orbital shaker. Samples were removed from PBS after 0, 60, 84, 108, 132, 
176, 200, and 240 hours, rinsed with deionized water, freeze-dried to remove moisture, 
and reweighed to determine the mass lost. To prevent saturation of solution, PBS was 
exchanged every other day. The result of the degradation study was calculated as the 
percentage of mass remaining, using 
𝑀𝑎𝑠𝑠	𝑅𝑒𝑚𝑎𝑖𝑛𝑖𝑛𝑔	(%) = 𝑀𝑥𝑀𝑜 	𝑥	100% 
where Mo is the initial mass of the construct and Mx is the final weight of the same 
construct after exposure to the degradation solution for x hours (n=3).20 
2.4.3 ATR-FTIR 
 In order to determine if any residues, either from the PVA or the solvent, remained 
following wash-out of the PVA, or if any alteration in the PGA:PEG bandage had occurred, 
completed constructs were analyzed by attenuated total reflection Fourier transform 
infrared (ATR-FTIR) spectroscopy using a Nicolet iS 10 FT-IR spectrometer 
(ThermoFisher Scientific, Waltham, MA) at a spectral range of 4000-600cm-1. This 
measurement evaluated the chemical composition of the electrospun fibers before and 
after removal of the PVA sacrificial elements to determine if processing altered the 
materials.21-22 
2.5 In Vitro Studies 
2.5.1 Cell Culture 
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Human bone marrow derived mesenchymal stem cells (hMSCs, 22 y/o, male, 
Lonza Biosciences, Walkersville, MD) were used between P4-P6. Cells were cultured in 
MSC growth media (MSCGM, Lonza Biosciences) in T-75 cell culture flasks at 37°C, 95% 
relative humidity, and 5% CO2 with media changes every three days. Cell culture flasks 
and other reagents were purchased from Fisher Scientific (Hampton, NH) unless 
otherwise noted. 
2.5.2 Biocompatibility Evaluation 
 We used two approaches to assess the effect of the bandage on a cell payload or 
on factors produced by those cells and released into the conditioned media.  The ability 
of human MSCs to undergo osteoblast differentiation was used as the model system.  In 
the first set of experiments, we examined the response of MSCs to construct degradation 
products.  In the second set of experiments we examined the osteoblastic differentiation 
of MSCs cultured on the polymeric scaffold. 
2.5.2.1 Effect of construct degradation products 
Two constructs were fully degraded in 50 mL growth media to form scaffold-
conditioned media (CM). 100μL of an hMSC suspension at a density of 200,000 cells/mL 
was seeded onto a 12-well tissue culture polystyrene (TCPS) plate with 500µL MSCGM. 
At 24h, MSCGM was removed, and 500 L of treatment media were added (MSCGM or 
CM). Media were exchanged every 48h thereafter until harvest at day 5 and at confluence, 
which occurred on day 7. Culture media were removed and stored at 4ºC.  The cell layers 
were rinsed with PBS and frozen with 1mL Triton X-100.  Upon thawing, cell layer lysates 
were homogenized by sonication. DNA content (QuantiFluor, Promega, Madison, 
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Wisconsin) and alkaline phosphatase specific activity (p-nitrophenol released from p-
nitrophenylphosphate at pH 10.25, normalized to the protein content of lysate) were 
measured. Conditioned culture media were used to assess release of specific proteins by 
cells. Enzyme-linked immunosorbent assays (ELISA) were used to quantify vascular 
endothelial growth factor-A (VEGF165, R&D Systems, Minneapolis, MN), bone 
morphogenetic protein 2 (BMP-2, PeproTech, Rocky Hill, New Jersey), osteocalcin (Alfa 
Aesar, Ward Hill, Massachusetts), and osteoprotegerin (OPG, R&D Systems) following 
the manufacturer’s instructions. Immunoassay results for each culture were normalized 
to total DNA content. 
2.5.2.2 Protein release by MSCs cultured within the PLG:PGA constructs 
Each construct used in this set of studies measured 2cm x 2cm and contained a 
three-layered void.  2.5x104 hMSCs suspended in 100µL of media were injected into the 
interior of the construct (via an 18-gauge needle) or seeded onto the surface of a TCPS 
12-well plate. Media were exchanged every 48 hours. On day 7, constructs were 
transferred to new well plates and fresh media were added. Conditioned media were 
collected 24 hours later (day 8). Cell layers or constructs were rinsed twice with PBS and 
frozen overnight at -20ºC in 1mL of 0.05% Triton X-100 until assayed.  Prior to analysis, 
the lysates were homogenized by sonication and spun in a plate centrifuge to pellet 
residual polymer to one edge of the plate. DNA content (QuantiFluor, Promega, Madison, 
Wisconsin) and alkaline phosphatase specific activity were analyzed as above. 
Conditioned media from the cultures were used to assess protein release by cells. For 
this study, we measured VEGF, fibroblast growth factor 2 (FGF-2), BMP-2, osteocalcin 
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and osteoprotegerin by ELISA (R&D Systems, Minneapolis, MN) and data were 
normalized to total DNA content. 
2.5.2.3 Effect of construct on MSC differentiation 
25,000 hMSCs were seeded into the construct void space or onto TCPS as 
previously described. After two days of culture in growth media, one half the cultures were 
treated with osteogenic media (OM) (Lonza). Media exchanges continued to occur every 
48 hours. On day 7, construct samples were transferred to a new plate and with fresh 
media (either GM or OM). 24 hours later (day 8), media were collected, samples and cell 
layers were rinsed twice with PBS before being lysed in 1mL of 0.05% Triton X-100. Both 
media and lysates were frozen overnight and stored at -80ºC.  Samples were processed 
as described above. 
2.6 Statistical Analysis 
The results of quantitative in vitro analyses were calculated as the means ± SD of 
six independent cultures per variable. Statistically significant differences between groups 
were determined by one-way ANOVA followed by Tukey’s modification of Student’s t-test. 
p values ≤0.05 were considered statistically significant. All in vitro experiments were 
repeated at least twice to ensure validity of results.  
3. Results 
3.1 Construct Fabrication and Characterization 
 In order to identify the best polymer(s) to meet our design criteria, we considered 
a number of options, including polycaprolactone (PCL), PGA, and PGA:PEG blends.  PCL 
failed to biodegrade over the time course used in the study and was eliminated. Although 
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PGA monomers are reported to be angiogenic and degradation of the polymer did occur 
in a time-appropriate manner, we were not able to reliably produce smooth fibers.  
Addition of PEG as a stabilizer resulted in smooth fibers and analysis of various 
combinations of PGA and PEG (Figure 2).  Based on this study, the best electrospinning 
parameters were: Solution=140:40 mg/mL PGA:PEG; Flow Rate=2mL/hr; Tip-to-
Collector Distance=20cm; Applied Voltage=12.5kV through an 18G blunt-tip needle. An 
SEM image of the PGA:PEG fibers produced using this method is shown in Figure 2. 
3.3 Construct Characterization 
3.3.1 Removal of PVA Sacrificial Elements 
 PVA sacrificial element templates printed at 5x normal size (Figure 3A) 
dissolved completely after 4 hours (Figure 3B). PVA wash out was confirmed in the final 
constructs based on SEM micrograph evaluation of samples before and after wash-out 
(Figure 4). No residue or foreign material could be identified, nor were there any 
morphological differences between pre- or post-wash fibers.  
ATR-FTIR spectra of ‘fresh’ and ‘washed’ constructs exhibited matching profiles (Figure 
5E), confirming that the process to wash out the PVA sacrificial elements did not 
chemically change the electrospun fiber material.3.3.1 Analysis of Fiber Dimensions and 
Degradation Kinetics 
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Figure 5: Scanning electron micrographs of electrospun fibers, top view, 1000x (A) 
and cross-section, 500x (B). Separation of layers created by 3D printed sacrificial 
elements is noted with white arrow. Distribution of fiber diameters (C), degradation 
profile (D), and Fourier transform infrared spectra of ‘Fresh’ and ‘Washed’ 
constructs, confirming no chemical alteration due to processing (E). 
The non-woven fibrous mesh fabricated by electrospinning resulted in a porous 
structure of sub-micron diameter fibers. Fibers had a smooth and consistent 
morphologies (Figure 5A). Cross sections of the mesh showed that fibers were well 
separated (Figure 5B) and had an average diameter of 0.55µm ±0.2µm and an average 
pore size of 3.8µm2 ± 2.7µm2 (Figure 5C).  
When constructs were incubated in aqueous solution, 75% of the electrospun 
fiber’s mass was lost by 10 days (Figure 5D). At this time, constructs lost mechanical 
stability and began to break apart.  
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3.4 In Vitro Studies 
3.4.1 Biocompatibility 
HMSC monolayer cultures that were treated with scaffold degradation byproduct 
conditioned media (CM) exhibited reduced DNA content (Figure 6A) and alkaline 
phosphatase specific activity (Figure 6B) compared to cultures treated with growth media 
(GM). These effects were seen on day 5 and day 7.  Production of VEGF was reduced 
with time, but the type of media had no effect on this parameter (Figure 6C).  In contrast, 
production of BMP-2 was markedly reduced in cultures treated with CM regardless of time 
(Figure 6D).  Osteocalcin production was increased on day 7 in CM treated cultures 
(Figure 6E) and osteoprotegerin was increased on day 5 in CM cultures (Figure 6F) 
compared to GM-treated cells.  
 
Figure 6: Response of hMSCs cultured with MSCGM media (GM) or construct 
degradation byproduct conditioned media (CM). DNA content (A) and alkaline 
phosphatase specific activity (B), with protein quantification by ELISA for VEGF-A 
(C), BMP-2 (D), osteocalcin (E), and osteoprotegerin (F). Data are from 
representative experiments and are presented as means + SD with n=6 
independent cultures, * significant vs GM, p < 0.05. 
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3.4.2 hMSC Response to Growth in the Bandage 
 Cells that were cultured in growth media within the bandage void space exhibited 
comparable growth at 8 days as was seen in cultures grown on TCPS (Figure 7A).  
However, alkaline phosphatase specific activity was markedly higher in the bandage 
cultures (Figure 7B).  Production of growth factors (FGF-2 [Figure 7C], VEGF [Figure 7D] 
and BMP-2 [Figure 7E]) was comparable under both culture conditions.  Similarly, 
production of osteocalcin (Figure 7F) and osteoprotegerin (Figure 7G) was unaffected by 
culture conditions.  
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Figure 7: hMSC response to culture within the construct vs. on TCPS. DNA 
content (A), alkaline phosphatase specific activity (B), FGF-2 (C), and VEGF-A (D). 
Osteogenic factors were also measured: BMP-2 (E), osteocalcin (F), and 
osteoprotegrin (G). Data are from one representative experiment and are 
presented as means + SD  DNA content per well, alkaline phosphatase specific 
activity normalized to protein, and specific proteins (C-G) normalized to DNA (n=6 
independent cultures; * significant vs TCPS, p < 0.05). 
3.4.3 hMSC Differentiation within the Bandage 
 After eight days of growth in either growth media or osteogenic media within the 
bandage void space, there was no difference in DNA content of cultures (Figure 8A).  
Alkaline phosphatase specific activity was significantly reduced in the OM cultures (Figure 
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8B) whereas production of osteocalcin was significantly increased (Figure 8C).  
Production of VEGF was comparable under both conditions (Figure 8D), BMP-2 was 
increased in OM (Figure 8E), and FGF-2 was decreased (Figure 8F). 
 
Figure 8: MSCs differentiate within construct in response to osteogenic media.  
DNA quantification (A), alkaline phosphatase specific activity (B), and levels of 
osteocalcin (C), VEGF-A (D), BMP-2 (E), and FGF-2 (F). Data are from one 
representative experiment and are presented as means + SD with n=6 
independent cultures; * significant vs GM, p < 0.05. 
 
4. Discussion 
The development of a resorbable dermal wound dressing capable of delivering 
cells to a wound site holds great potential for a variety of applications. Here, we show that 
an electrospun construct can be fabricated with an internal reservoir through the use of 
3D printed sacrificial elements. The enclosed void space left by the removal of the 
sacrificial elements provides room for cells to be delivered. It is important that the 
sacrificial elements are in contact with one another during fabrication to ensure each layer 
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of the ‘reservoir’ is interconnected to form a single volume. This method is a significant 
improvement over other sacrificial element techniques, often using a porogen to 
manipulate scaffold architecture. This aids the seeding process, allowing a single cell 
suspension injection to reach all levels of the construct. The presence of electrospun fiber 
layers through the “reservoir” maximizes the surface area available for cell attachment.  
The space left by sacrificial elements may also be used to better localize therapeutic 
agents that are typically delivered as hydrogels or microparticles.23  
Incorporating PEG to the polymer blend not only served as a stabilizer to facilitate 
electrospinning, but also made the fibers more hydrophilic.  Moderate hydrophilicity has 
been reported to improve protein adsorption and result in better biocompatibility.24-28 
PEG, which is highly hydrophilic, also reduces the degradation timeframe of the polymer 
fibers to 10-14 days, which is well coordinated with the documented timeline for full-
thickness wound re-epithelialization and angiogenesis. These processes are known to 
occur around 7 days, or once the granulation tissue has begun to reestablish the wound 
bed.29  As the construct continues to break down, cells from the surrounding tissue are 
able to more easily infiltrate the wound site and begin the regeneration and remodeling 
process. Reestablishment of the absent or damaged tissue is crucial to positive patient 
outcomes. 
In vitro evaluation of the construct has shown it to be supportive of cell growth with 
minimal influence on cell behavior. Seeding the constructs through suspension injections 
allows the cells to migrate out through the porous fiber mesh, as opposed to traditional 
top seeding, which uses gravity to aid cell infiltration. Although the degradation products 
did have effects on the cells in cultures, it should be noted that cells cultured within the 
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construct or migrating to the construct would not experience such high levels of 
degradation byproducts in vivo. Even though media changes reduced exposure to 
byproducts in vitro, clearance via natural fluid exchange (in vivo) would prevent the 
accumulation of degradation byproducts on a continuous basis. 
Cells remained viable in the constructs over the 8 day culture period with little 
alteration in growth parameters compared to MSCs grown on TCPS.  Only alkaline 
phosphatase specific activity was elevated.  The meaning of this isn’t clear.  One 
possibility is that the bandage cells maintained their multipotency, which is ideal in the 
absence of systemic cues or local factors.30 In contrast, when cells were cultured in OM, 
alkaline phosphatase was decreased, and osteocalcin production was increased.  This 
suggests the possibility that cells within the constructs were undergoing osteogenic 
differentiation even in GM and this was accelerated when they were grown in OM.  
Reduced alkaline phosphatase together with increased osteocalcin is a marker of a well-
differentiated osteoblast.31 Further support for this is that BMP-2 was also increased in 
the OM cultures, which potentially contributed to the marked increased in osteocalcin.   
5. Conclusion 
In this study, a resorbable electrospun wound dressing was prepared that is 
capable of delivering a payload of cells in effort to enhance defect healing. The PVA 
sacrificial elements provided an interconnected internal void space and the PGA:PEG 
blend proved to be degradable along the same 10-14 day timeframe coinciding with 
normal wound healing. The results indicate that the ability to differentiate is retained by 
MSCs cultured within the construct and suggest that factors present in the wound site 
may contribute to the determination of cell fate.  This highlights the potential of pre-treating 
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cells or incorporating factors into the polymer blend to further direct the healing and 
regeneration process. The combination of 3D printing and electrospun fibers opens 
possibilities of unique architectures and brings us closer to individualized medicine.  
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Abstract 
Burns and chronic wounds are especially challenging wounds to heal. In efforts to heal 
these wounds, physicians often use autologous skin grafts to help restore mechanical 
and barrier functionality to the wound area. These grafts are, by nature, limited in 
availability. In an effort to provide an alternative, we have developed an electrospun 
wound dressing designed to incorporate into the wound with the option to deliver a cellular 
payload. Here, a blend of polyglycolic acid (PGA) and polyethylene glycol (PEG) was 
electrospun as part of a custom fabrication method that incorporated 3D printed polyvinyl 
alcohol (PVA) sacrificial elements. This preparation is unique compared to traditional 
electrospinning as sacrificial elements provide an internal void space for an injectable 
payload to be delivered to the wound site. When the construct was tested in vivo (full 
thickness excisional skin wounds), wound closure was slightly delayed by the presence 
of the scaffold in both normal and challenged wounds. Quality of healing was improved 
in normal wounds as measured by histomorphometrics when treated with the construct 
and exhibited increased neo-vascularization. Stem cell delivery in conjunction with a 
resorbable extracellular matrix-like scaffold is beneficial to healing of full thickness skin 
defects and may benefit challenged wounds. 
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1. Introduction 
Large or chronic dermal wounds are unable to restore the barrier that usually 
protects the body’s internal environment without acute medical intervention. The result 
can reduce the patient’s quality of life and lead to loss of limb or life. Each year 
approximately 5.7 million patients seek treatment for dermal wounds in the U.S. alone, 
costing an estimated $25 billion. In addition to this, nearly 500,000 patients seek 
treatment for burn and other injuries requiring skin grafts [1]. Current treatments for 
dermal wounds include autografts, allografts, xenografts and more recently synthetic 
dressings or skin substitutes. Autografts, the gold standard for skin grafts, minimize the 
possibility of rejection or disease transmission through their inherent nature of being the 
native tissue [2]. This procedure leaves a painful secondary wound site and processing 
the skin undergoes before application often leads to extensive scarring [3].  
Tissue engineering approaches to treating dermal wounds have gained popularity 
in the recent years. Acellular grafts, made of collagen, hyaluronic acid, or decellularized 
matrices are becoming more popular [4-6]. Synthetic cellular grafts made of 
biodegradable films cultured with autologous, allogeneic or recombinant skin cells have 
begun to be made commercially available [7]. Although the use of engineered grafts is a 
step forward in wound healing technology, they experience some of the drawbacks of 
conventional skin grafts, such as a high risk of rejection, transmission of infection, excess 
scarring, and expense to the patient and care providers [3]. Therefore, there is a great 
need for a synthetic, off-the-shelf wound dressing that can be integrated to the tissue as 
a graft. 
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 Electrospinning, a versatile process that can produce micro- to nano-sized fibers 
from a polymeric solution, can closely mimic the extracellular matrix [8, 9]. We applied 
this technique to produce a randomly oriented microfiber scaffold from two polymers, 
poly(glycolic acid) (PGA) and poly(ethylene glycol) (PEG), with an addition of a void space 
pocket to allow for a payload of cells or therapeutic agents. PGA is a biodegradable 
polymer that is found most commonly in absorbable surgical sutures. PGA has been 
shown to support a variety of cells [10-12] and can also result in an acidic 
microenvironment at the wound site [13], which has been shown to have pro-angiogenic 
influences [14]. PEG is a water-soluble polymer that serves to aid in the electrospinning 
process and increase the degradation rate. The combination of these two FDA approved 
polymers facilitates more uniform electrospun fibers, as well as allowing modification of 
the degradation timeframe [15]. The randomly oriented fibers of the scaffold allow native 
cells from the wound site to attach and begin their healing and remodeling processes [16].  
By incorporating an internal void space, a payload can be delivered to the wound 
site. The addition of encapsulated mesenchymal stem cells (MSCs) and adipose derived 
stem cells (ASCs) to wound sites has been noted to improve healing and regeneration 
outcomes, in part by stimulating angiogenesis via the production of angiogenic factors 
[17-21]. However, many of the approaches used to deliver MSCs have size constraints 
affecting diffusion of nutrients and waste products.  Using 3D printing, nearly limitless 
configurations of the cargo area can be designed and included within the construct. Here 
we chose a 1cm x 1cm square template as this resulted in a construct that nicely fit the 
selected wound model.   
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 The aim of this study was to evaluate the in vivo effectiveness of a resorbable 
dermal wound dressing that could deliver and localize a payload of cells while serving as 
a matrix for host cell ingrowth. Previous in vitro studies in our lab showed that human 
MSCs cultured in this scaffold remained viable over time and produced factors that were 
secreted into the surrounding media.  Moreover, the cells responded to exogenous 
factors, indicating that their ability to differentiate was not impeded by the polymer scaffold 
(Clohessy et al. Development of a biodegradable three-dimensional cell delivery 
bandage. Mater Sci Eng C Mater Biol Appl. Under Review).  Based on these in vitro 
observations, the construct was hypothesized to support tissue regeneration and aid in 
the wound healing process with pre-seeded constructs further improving healing in full-
thickness dermal wounds.  To test this hypothesis, we applied both seeded and unseeded 
constructs to full thickness excisional wounds. The effects on wound closure, tissue 
regeneration, and angiogenesis were investigated using both normal and ischemic wound 
models. 
2. Materials and methods 
2.1 Construct fabrication  
Electrospun constructs were fabricated using a combination of techniques, as described 
previously (Clohessy et al. Development of a biodegradable three-dimensional cell 
delivery bandage. Mater Sci Eng C Mater Biol Appl. Under Review). Sub-micron fibers 
were vertically electrospun using a solution of 140 mg/mL polyglycolic acid (PGA, i.v. 1.0-
2.0, Polysciences Inc., Warrington, PA) and 40 mg/mL polyethylene glycol (PEG, 
Mw=20,000, Sigma Aldrich, St. Louis, MO) in 1,1,1,3,3,3-hexafluro-2-propanol (HFIP, 
Sigma Aldrich). The polymer was extruded through a blunt-tipped 18-gauge needle at 
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2mL/h with an applied voltage of 12.5 kV onto a flat aluminum foil target at a 30cm 
collection distance. Layers of electrospun fibers were alternated with 3D printed void 
templates until the seven-layer construct was complete. Before positioning the second 
and third layers of 3D printed sacrificial elements, small cuts were made in the covering 
electrospun fiber layer to allow contact between sacrificial elements along two parallel 
edges. These cuts allowed the sacrificial elements to form one interconnected “reservoir.” 
The 1cm x 1cm x 0.08cm 3D printed sacrificial elements were printed from 1.75mm 
diameter polyvinyl alcohol filament (Ultimachine, South Pittsburgh, TN) on a MakerBot 
Replicator 2X (MakerBot, New York, NY) and designed for interconnection. The 
completed “fresh” constructs were then soaked in deionized water (DI-H2O) for 24 h to 
remove the PVA void templates, leaving an interconnected void within the electrospun 
fibers of the “washed” construct. A schematic of the process can be seen in Figure 1A. 
Sterilization of the construct was accomplished by soaking in 70% ethanol for 1 h followed 
by three five-minute rinses in sterile PBS under aseptic technique.  
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2.2 In vivo model 
Both normal and compromised (ischemic) full-thickness wounds were used to 
evaluate the effects of the construct. All experiments were conducted under an approved 
Institutional Animal Care and Use protocol at Virginia Commonwealth University.  
Skeletally mature, male Sprague Dawley rats weighing 400 ± 25g were obtained from 
Harlan Laboratories (Indianapolis, IN). Rats were given full anesthesia through flowing 
isoflurane (1.5% in 1 L/min O2); afterward, the hair over the dorsum was clipped and the 
skin was scrubbed with 70% ethanol solution and chlorhexidine to prepare for wounding. 
Subcutaneous injections of extended release analgesic, buprenorphine XR, were 
B C 
Exposed “shoulders” 
A 
Figure 1: Schematic of fabrication process (A). Photograph of construct as-
fabricated (B), and bisected to reveal internal composition (C). 
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administered at 1.2mg/kg body weight immediately preceding surgery. The center of each 
wound was marked 1.5cm below the scapula and 1.0cm to either side of the spine. Prior 
to wound creation, silicone doughnuts 2cm in diameter with 1.5cm inner diameter and 
thickness of 1.7mm (GBL665283, Grace Bio-Labs, Bend, OR) were fixed around the 
wound site using surgical glue (Henry Schein, Melville, NY) and sutured in place (Look 5-
0 Black Mono Nylon Sutures, Ace Surgical, Brockton, MA). Within each doughnut, a 
10mm full-thickness wound was made with a sterile biopsy punch (NC9226137, Fisher 
Scientific, Hampton, NH). The doughnuts were used to prevent wound contraction and 
allow the wound to heal by secondary intention in an effort to make the model more 
analogous to human wound healing [22-24]. Wound contraction in rat models is a well-
documented phenomenon, yet is predominantly ignored throughout the literature [25-27].  
An ischemic model was used to model compromised wound healing [28]. In this 
model, both splinted wounds were within a 4.25cm by 3cm, cranially oriented, ¾ pedicle 
flap that was separated from the underlying fascia with a 4cm x 3cm x 0.5mm silicone 
isolator sheet (GBL665283, Grace Bio-Labs, Bend, OR). Isolators were sutured in place 
with undyed 5-0 PGA sutures (PSN421V, Hu-Friedy, Chicago, IL). 
All constructs were sutured in place with PGA sutures and wounds were covered 
in a clear wound dressing (Tegaderm, 3M Health Care, St. Paul, MN), padded with steam 
sterilized gauze and wrapped in elastic fabric tape. Upon recovery from anesthesia, 
animals were returned to their singly housed home cage. Surgeries were conducted in a 
random order with respect to model, treatment group. At the end of the study, animals 
were euthanized by CO2 asphyxiation. All in vivo experiments were approved by VCU 
Institutional Animal Care and Use Committee (IACUC). 
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2.2.1 Animal study #1 
The first in vivo study was designed to evaluate the effects the construct alone may 
have on wound healing while ensuring no adverse effects resulting from implantation. 32 
rats underwent the surgical procedure described above. One wound in each animal was 
treated with an electrospun construct, while the other was left untreated as a control. 
Animals were imaged every other day and allowed to heal for 10 or 21 days. Eight wounds 
were examined for each group (Empty or Construct) in each of the normal and ischemic 
models at each time point. Wounds and surrounding tissue were harvested for histology, 
qualitative grading, and quantitative histomorphometric measurements.  
2.2.2 Animal study #2 
A second study was designed to evaluate the constructs pre-seeded with stem 
cells. Sprague Dawley rat ASCs were selected to avoid the possibility of xenogenic 
rejection. ASCs that had been isolated from the inguinal fat pads of male Sprague Dawley 
rats were used between P4-P6. Cells were cultured in T-75 cell culture flasks at 37°C, 
95% relative humidity, and 5% CO2 with MSCGM basal media (Lonza, Basel, 
Switzerland) changes every three days. Cell culture components and other reagents were 
purchased from Fisher Scientific (Hampton, NH) unless otherwise noted.  Prepared 
constructs were seeded with 50,000 ASCs 48 hours before implantation and cultured in 
MSCGM supplemented with 10% Sprague Dawley rat serum (Innovative Research, Novi, 
MI).  
Both the normal and ischemic models were used with treatment groups consisting 
of: empty (negative control), unseeded construct, or seeded construct. 24 animals 
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underwent the procedure described above with four animals in each group. Both wounds 
in each animal received the same treatment group in order to prevent implanted cell 
migration or construct degradation byproducts from affecting the contralateral wound. 
Animals were imaged every other day and allowed to heal for 21 days. In this study, only 
one timepoint was selected to evaluate the wounds once the constructs had degraded. 
Wounds and surrounding tissue were harvested for histology, qualitative grading, 
quantitative histomorphometric measurements and immunohistochemistry. Eight wounds 
were examined for each group (Empty, Unseeded, Seeded) in each of the normal and 
ischemic models. 
2.3 Wound closure analysis 
Dermal wounds were imaged every other day. Wound area was quantified by 
tracing the wound border in each photograph (ImageJ v1.48, NIH, Bethesda, MD). The 
scale was set to a ruler photographed with each wound and wound percentage was 
calculated as follows: 
Relative	Wound	Area = Area	on	day(n)Area	on	day(1) 
2.3.1 Histology  
 Wounds and surrounding tissue (2cm x 2cm) were resected and fixed overnight in 
10% neutral buffered formalin. Samples were processed (STP 120, Thermo Fisher 
Scientific, Waltham, MA) and embedded in paraffin. Histological sections (5µm thickness) 
were stained with H&E. Slides were imaged using transmitted light bright field microscope 
(Zeiss Observer Z1, Oberkochen, Germany) equipped with a 2.5x objective and 10x 
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optical zoom. Images were captured by an AxioCam MRc5 camera with Zeiss ZEN Pro 
Blue Edition software (Oberkochen, Germany). 
2.3.2 Quantitative histomorphometrics 
 From images of the H&E stained sections, quantitative histomorphometrics were 
performed measuring the abnormal tissue length, distance un-epithelialized, and wound 
thickness ratio using criteria adapted from adapted from Lemo et al. 2010. Abnormal 
tissue length represents the distance of the wound that has not been remodeled. Un-
epithelialized distance represents the length of tissue not epithelialized or a gap in the 
tissue. The wound thickness ratio represents the average thickness of the visible wound 
area relative to the average thickness of the healthy tissue along the margins of the 
wound.  
2.3.4 Qualitative histological grading 
 H&E stained sections were blindly graded by three trained graders. Grading criteria 
was adapted from Altavilla et al. [29]; Sections were scored on a scale of 0-4 in epidermal 
regeneration, dermal regeneration and granulation tissue thickness (see Table 1).  
2.3.4 Immunohistochemistry  
To evaluate the effect of constructs on angiogenesis, sections were fluorescently 
stained for alpha smooth muscle actin to identify blood vessels [30]. Antigen retrieval was 
performed on deparaffinized samples in 1mM EDTA at pH 8.0 at 95°C for 5min, and then 
cooled to room temperature. Samples were then rinsed and blocked with StartingBlock 
(PI37538, Thermo Fisher Scientific). Anti-alpha smooth muscle actin primary antibody 
(ab5694, abcam, Cambridge, UK) was applied overnight at a 1:250 dilution in PBS, 0.05% 
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Tween 20. The secondary antibody, Goat anti-mouse IgG Alexa Fluor 488 (Invitrogen, 
A11001) secondary antibody was applied for two hours at 1:200 dilution in PBS, 0.05% 
Tween 20, 1% BSA and counterstained with pentahydrate (bis-benzimide) for 20 minutes 
(Hoechst 33258, Molecular Probes, Eugene, OR). Slides were then imaged using 
fluorescent light on a Zeiss Observer Z1 microscope equipped with a 2.5x objective and 
10x optical zoom. Images were captured by an AxioCam MRc5 camera and images were 
compiled using Zeiss ZEN Pro Blue Edition software. 
2.4 Statistical analysis 
Experiment analyses were calculated as the means ± SEM of eight samples per 
variable. Statistically significant differences between groups were determined by one-way 
ANOVA followed by Tukey’s modification of Student’s t-test. p values ≤0.05 were 
considered statistically significant. 
3. Results 
3.1 Construct fabrication 
 The appearance of an ‘as-fabricated’ construct can be seen in Figure 1B with an 
exploded view (Figure 1C) highlighting the internal, interconnected PVA sacrificial 
elements interpolated with electrospun fibers (red arrows).  PVA was found to fully 
dissolve in static H2O within 4 hours, and when enveloped in electrospun fibers, within 24 
hours. All samples underwent 24 hours of PVA washout before disinfection and use in 
described studies. 
3.2 In vivo study #1 
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 Electrospun constructs had no adverse effects on the animals' overall health or 
wellbeing over the course of the study. In normal wounds, closure was slightly delayed 
by the construct at day 10, but quickly recovered to the empty control (Fig. 2A).  
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Figure 2: In vivo study #1 results with wounds treated with unseeded constructs or 
left empty.  Wound closure data for normal (A) and ischemic (B) wounds over time. 
Histomorphometrics for normal wounds (C-E) and ischemic wounds (F-H). Scores 
from H&E grading for normal wounds (I-K) and ischemic wounds (L-N). 
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However, in the ischemic wounds there was greater divergence between the empty and 
construct treated wounds, with days 14-21 having significantly larger wound areas (Fig. 
2B). The construct treated ischemic wounds did not successfully heal and maintained a 
wound area nearly 80% of the original for the duration of the study.  
Representative images of H&E staining of histological sections for the four groups 
(normal empty, normal construct treated, ischemic empty, ischemic construct treated) can 
be seen in Figure 3. At 10 days, the scaffold treated normal wounds measured thicker 
relative new tissue depth compared to all other groups (Fig. 2E).  
At 21 days, the construct treated ischemic group had a significantly thinner new 
tissue depth and a higher incidence of remaining unepithelialized area (Fig. 2, F-G). The 
scaffold treated normal group had re-epithelialization in all samples (Fig. 2 D, G). 
Scoring of the wounds (Fig. 2, C-N) revealed lower dermal regeneration of the 
construct treated wounds in both the normal and ischemic groups. The construct was also 
found to have a lower score in the granulation tissue thickness category for the ischemic 
model.  
Fluorescent staining for α-SMA, indicated blood vessels within the regenerating 
tissue. Construct treated normal wounds had significantly higher number of blood vessels 
per field of view, roughly three times higher than wounds left empty. The ischemic wounds 
lacked significance, but also maintained a higher average than the empty groups. 
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Figure 3: Representative H&E stained slides for normal empty (A), normal 
construct treated (B), ischemic empty (C), and ischemic construct treated (D) at 
2.5x in the left column.  Pop-outs are10x regions of interest with granulation tissue, 
dermal regeneration, and epidermal regeneration labeled with white letters G, D, 
and E respectively. 
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3.3 In vivo study #2 
 The relative wound area for either seeded or unseeded construct treated wounds 
in the normal animals was significantly different from the empty treatment at days nine 
and 11, with the unseeded group continuing to be different from the empty treatment 
through day 13 (Fig. 4, A-B). In the ischemic animals the findings were statistically 
indifferent to the treatment group. The normal animals were able to completely close the 
wounds while the ischemic animals maintained a wound area at the end of the study. It 
was noted that the wound splints began to fail at day 15, which could lead to inaccurate 
wound closure measurements. Due to this, the data presented are for the days that the 
splints remained intact (d0-d15). 
Histological morphometric measurements (Fig. 4, C-H) and scoring (Fig. 4, I-N) 
failed to find many significant differences, the only being the unseeded construct-treated 
normal wound had less dermal regeneration than the empty normal wound. 
Representative images of H&E stained sections can be seen in Figure 5.  
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Figure 4: In vivo study #2 results with wounds treated with seeded constructs, 
unseeded constructs or left empty.  Wound closure data for normal (A) and 
ischemic (B) wounds over time. Histomorphometrics for normal wounds (C-E) and 
ischemic wounds (F-H). Scores from H&E grading for normal wounds (I-K) and 
ischemic wounds (L-N). 
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Figure 5: Representative images of 2.5x H&E stained sections with normal wounds 
(left) and ischemic wounds (right) and left empty (first row), treated with an 
unseeded construct (second row) or a ratASC seeded construct (third row). Wound 
margins are noted with dashed line. 
Immunohistochemical staining of α-smooth muscle actin was again able to identify 
a nearly three-fold increase in blood vessels found within sections of normal wounds 
treated with either seeded or unseeded constructs (Fig. 6, A-B). Differences were not 
found among the ischemic wounds.  
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Figure 6: Average blood vessel counts per field of view for normal (A) and 
ischemic (B) wounds. Empty and unseeded groups are from both in vivo studies. 
4. Discussion 
The development of a resorbable dermal wound dressing capable of delivering 
cells to a wound site holds great potential. Here, we show that an electrospun construct 
can be fabricated with an internal reservoir through the use of 3D printed sacrificial 
elements. The enclosed void space left by the removal of the sacrificial elements provides 
room for cells to be delivered. It is important that the sacrificial elements are in contact 
with one another during fabrication to ensure each layer of the ‘reservoir’ is 
interconnected to form single volume. This method is a significant improvement over other 
sacrificial element techniques often using a porogen to manipulate scaffold architecture. 
This aids the seeding process, allowing a single cell suspension injection to reach all 
levels of the construct. The presence of electrospun fiber layers through the “reservoir” 
maximizes the surface area available for cell attachment.  The space left by sacrificial 
elements may also be used to better localize therapeutic agents that are typically 
delivered as hydrogels or microparticles [31].  
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In these studies, we see the normal wounds were able to develop more granulation 
tissue in the wound site than the ischemic wounds. This is due to the basement of the 
wound being able (normal wounds) or unable (ischemic wounds) to participate in 
replenishing the defect.  Re-epithelialization of the wounds was found to be faster in the 
construct treated groups suggesting that at earlier times, the scaffold may act as a 
substrate for the native keratinocytes to repopulate the wound area. The increase in blood 
vessels found in both studies is believed to be a result of the construct degrading and 
creating an acidic microenvironment. Low microenvironmental pH is known to be pro-
angiogenic through the induction of vascular endothelial growth factor (VEGF) via the 
hypoxia-inducible transcription factor (HIF)-1 pathway [14]. The increase in neo-
vascularization supports the construct is able to aid wound healing. 
This study has also found delays in wound closure rates for samples treated with 
the constructs. Although the constructs are shown to support cell attachment, re-
epithelialization, and increased angiogenesis, they may also act as a physical barrier to 
the proliferation and remodeling by native cells. This was found to persist until 
approximately day 10 when the construct had degraded enough to allow for complete 
infiltration and wound closure. The ischemic wounds lacked the clearance to efficiently 
degrade the scaffold, which visibly remained through 21 days. A result of the ischemic 
isolator, the limited profusion and low volume of healthy tissue in contact with the wound 
site was severely limiting in regenerative ability and has proven an extremely challenging 
model to successfully heal. The lack of differences between the seeded construct and the 
unseeded or empty control among the histomorphometrics and wound closure rates was 
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surprising considering the beneficial effect exogenous MSCs have on wound healing, 
namely their ability to recruit other host cells and secrete growth factors [32]. 
Conclusion 
 In this study, a resorbable electrospun wound dressing was prepared that was 
capable of delivering a payload of cells in effort to enhance the healing of dermal defects. 
Delivered cells maintained their behavior in vitro, but at this stage were ineffective in 
accelerating wound healing in vivo. Despite marginal healing in vivo, the construct could 
easily be used as a delivery device for a variety of therapeutics such as an analgesic, an 
anti-microbial or anti-scaring agent. Results confirm the construct can serve as a 
substrate for re-epithelialization and increase blood vessel formation in the normal wound 
model. This increase in vascularity over the untreated wounds is significant as 
vascularization is paramount to healing potential. The ischemic model was successfully 
implemented as a compromised wound model but proved exceptionally challenging to 
heal. This study is also believed to be the first where both wound splints and an ischemic 
model were used simultaneously. Although the construct did not augment wound closure 
at this stage, the technology remains a promising option for a resorbable, therapeutic 
delivering wound dressing. It is also important to note that the speed of healing is directly 
related to the quality of regenerated tissue, with very rapid wound closure often leading 
to extensive scarring, thus the delayed wound closure found in construct treated wounds 
may not be explicitly detrimental. Evaluating the wound closure at a later time would allow 
the evaluation of the regenerated skin quality opposed to wound size and histological 
analysis conducted here. Improving construct integration as well as potentially adding 
exogenous factors to push differentiation, pretreating loaded cells, or seeding multiple 
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types of cells may also improve the efficacy of the wound dressing and must be further 
investigated the construct’s full potential in multiple applications 
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CHAPTER 4 
Conclusion 
 This thesis has presented multiple studies that indicate the potential of an 
electrospun and 3D printed cellular delivery device that holds great promise for 
individualized medicine.  Being the first to combine 3D printing with an electrospun 
biomaterial, this project investigates uncharted territory.  Beginning with the design and 
iterative development followed by in vitro and in vivo experiments, these studies have 
shown the construct to be capable of supporting cell growth and deserving of continued 
refinement.   
Using techniques of additive manufacturing, the construct was formed through a 
layered approach.  Electrospinning produced a non-woven fibrous mesh mimicking that 
of the native ECM.  This synthetic ECM provided a substrate for cellular growth and 
formed the base of the cellular delivery device.  Alternating layers of electrospun fibers 
and 3D printed sacrificial elements, an interconnected void space resulted from the 
dissolution of the sacrificial elements. This novel technique and the utilization of 3D 
printing allows for nearly any shape to be fabricated to match the needs of a patient, 
bringing individualized medicine to the treatment of dermal wounds. 
Development of the polymer solutions led to the inclusion of polyethylene glycol 
to improve the electrospinning characteristics.  While the incorporation of PEG was able 
to induce uniform fiber formation, the selection of high molecular weight PEG helped to 
tailor the degradation characteristics.  Low molecular weight PEG created more sites for 
hydrolysis once dissolved out causing degradation rates that were too fast.  Larger 
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molecules of PEG created fewer gaps in the polyglycolic acid chains, creating a 
degradation rate that was more appropriate for the wound healing timeline.  In vitro 
degradation proved to be faster in vivo than in vitro which is surmised to be due to 
cellular enzymatic activity in addition to hydrolysis.  Potentially contributing to the slower 
degradation rate in vitro, the pH of the saline degradation solution was found to be 4.88.  
This low pH may have inhibited or slowed hydrolysis.  Characterization of the construct 
showed that the diameter of the electrospun fibers were of the proper scale to match 
that in the established literature.  The pore size of the electrospun fibers were also 
found to be of the appropriate size, small enough to prevent cells from falling through, 
yet large enough to allow cellular infiltration.   
When seeded with mesenchymal stem cells, cultures on constructs exhibited the 
ability to proliferate while displaying characteristics to suggest a retained stemness.  
ASCs seeded within the construct were also able to be pushed toward an osteogenic 
lineage, shown through differentiation markers presented under an osteogenic media 
treatment.   
In vivo, the construct was unable to accelerate wound healing but had no host 
rejection, a major target and accomplishment for implantable biomaterials.  Interestingly, 
wounds treated with constructs did have significantly higher occurrences of blood 
vessels within the wound area suggesting the constructs were conducive to 
angiogenesis.  A consistently high level of granulation tissue found in histologic sections 
of construct treated wounds may be due to possible excipients from the ethanol 
sterilization process.  It is also important to consider the great challenges of the 
ischemic model, which could not support angiogenesis as the wound be was isolated 
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from the necessary stem cells in the underlying fascia.  Although the construct was sub-
optimal in the ischemic model, the in vivo studies were among the first to combine the 
wound splinting and ischemic techniques. 
Future work with the electrospun delivery device should focus on the fate of 
delivered cells.  Considering this, in vitro work with the constructs could be conducted 
with a single layer control to better evaluate cell proliferation with respect to provided 
surface area. In vivo, seeded cells could be pre-conditioned to encourage healing and 
be pushed to further support angiogenesis and host cell migration.  A closer 
examination of the molecular biology of the wound may elucidate cell behavior and fates 
most supportive of regeneration.  The pH of the wound exudate was not considered at 
the time of in vivo experimentation but could provide some insight to the mechanism of 
degradation and impact of the construct in situ.  Finally, this construct has great 
potential to be tailored or modified to include antimicrobial factors, or possibly different 
factors to be released from each layer of the construct.  Ultimately, a perfect 
incorporation and resorption into the wound will lead to regeneration and remodeling, 
bridging the gap between injured and normal states. 
The concept of individualized medicine is quickly becoming a reality as 
technology and creativity combine to produce novel treatments with the potential to 
improve patient outcomes.  Although imperfect in the current form, continued advances 
in engineering and medicine will see novel designs and raw science  sculpt the 
healthcare of the future and help realize the full potential of this work. 
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